Our Adherence to Quality Guarantees Consistent Quality in Clinical Trial Executions and Outcomes
A New Era in Clinical Research Practices
"Continuing to do things the same way, expecting a different outcome is insanity!"
This thought-provoking quote from Albert Einstein perfectly captures the challenges within today's clinical research landscape. For too long, outdated approaches and a lack of inclusivity have hindered progress in developing therapies that truly serve everyone.
TruVision Clinical Research is here to change that narrative.
Our Story
TruVision Clinical Research Partners (TVCRP) was founded with a singular goal in mind—to revolutionize clinical trials through innovation, inclusivity, and excellence. Born out of a vision to bridge gaps in healthcare and ensure that every community has access to effective medical solutions, we specialize in designing and executing clinical trials that are not only inclusive but also aligned with the highest industry standards.
Every breakthrough in medicine relies on accurate, representative data, and at TVCRP, we’ve made it our mission to ensure that clinical trials reflect the diversity of the populations they aim to serve. Guided by this principle, we’ve developed a holistic approach to trial management that prioritizes aggressive recruitment of underrepresented subpopulations, patient retention, and cutting-edge technological integration.
At TVCRP, we dare to do things differently, championing change in an industry that is vital to the future of global healthcare.
Our Clinical Research Consortium Accelerates Trials
Our Clinical Research Consortium is a strategic alliance of clinical sites, contract research organizations (CROs), and industry sponsors—working together to transform how clinical trials are designed and executed. With a shared commitment to innovation, speed, and quality, the consortium streamlines operations across the trial lifecycle and ensures a more connected, efficient, and patient-centric research model.
A core pillar of our consortium is our Decentralized Clinical Trial (DCT) capability, which empowers sites and sponsors to reach broader, more diverse patient populations. Through remote monitoring, telemedicine, home health services, and digital data collection, we reduce participant burden, accelerate recruitment, and improve retention—all while maintaining data integrity and regulatory compliance.
Our Clinical Research Consortium is a strategic alliance of clinical sites, contract research organizations (CROs), and industry sponsors—working together to transform how clinical trials are designed and executed. With a shared commitment to innovation, speed, and quality, the consortium streamlines operations across the trial lifecycle and ensures a more connected, efficient, and patient-centric research model.
A core pillar of our consortium is our Decentralized Clinical Trial (DCT) capability, which empowers sites and sponsors to reach broader, more diverse patient populations. Through remote monitoring, telemedicine, home health services, and digital data collection, we reduce participant burden, accelerate recruitment, and improve retention—all while maintaining data integrity and regulatory compliance.
Clinical Research Consortium to Accelerate Trials
Clinical Research Consortium to Accelerate Trials
Our Clinical Research Consortium is a strategic alliance of clinical sites, contract research organizations (CROs), and industry sponsors—working together to transform how clinical trials are designed and executed. With a shared commitment to innovation, speed, and quality, the consortium streamlines operations across the trial lifecycle and ensures a more connected, efficient, and patient-centric research model.
A core pillar of our consortium is our Decentralized Clinical Trial (DCT) capability, which empowers sites and sponsors to reach broader, more diverse patient populations. Through remote monitoring, telemedicine, home health services, and digital data collection, we reduce participant burden, accelerate recruitment, and improve retention—all while maintaining data integrity and regulatory compliance.
Seamless Collaboration for Faster, Smarter Clinical Trials
By integrating site-level expertise, CRO operational infrastructure, and sponsor-driven innovation under a unified governance model, the consortium supports early protocol input, harmonized workflows, rapid site activation, and real-time data sharing. This collaborative framework leads to faster startup, better patient engagement, and lower trial costs - bringing therapies to market more efficiently.
Together, we are redefining what's possible in clinical research.
Seamless Collaboration for Faster, Smarter Clinical Trials
By integrating site-level expertise, CRO operational infrastructure, and sponsor-driven innovation under a unified governance model, the consortium supports early protocol input, harmonized workflows, rapid site activation, and real-time data sharing. This collaborative framework leads to faster startup, better patient engagement, and lower trial costs - bringing therapies to market more efficiently.
Together, we are redefining what's possible in clinical research.
Our Founder
Brian A. Stone MD, FACS
Dr. Stone has dedicated nearly four decades to advancing the fields of urology and clinical research, with a focus on diversity and inclusivity in healthcare. After completing his medical training in general surgery and urology at Montefiore Medical Center and Albert Einstein College of Medicine, he pursued two fellowships in Neuro-urology and male sexual dysfunction, further solidifying his expertise.
Early in his career, Dr. Stone played a pivotal role as co-principal investigator in a groundbreaking clinical trial for BPH medication in 1988. This pivotal experience marked the beginning of his passion for clinical research. He left his residency to join the faculty at the College of Physicians and Surgeons at Columbia University in the Department of Urology, where he served as the principal investigator for numerous pharmaceutical, biotech, and device trials.
A consistent advocate for inclusivity in clinical science, Dr. Stone has focused much of his work on addressing disparities in research and patient recruitment. Troubled by the lack of representation of African Americans, Hispanics, and Asians in pivotal clinical trials, he has been a vocal champion for the inclusion of diverse populations in studies to ensure results are applicable across all groups.
Dr. Stone's commitment to inclusive research extended to his work as a contributor to the African American Familial Prostate Cancer sub-study of the Human Genome Project, under the leadership of renowned researchers Drs. Francis Collins, John Carpten, and Rick Kittles. Through this project, he witnessed firsthand how representation at all levels of research—from study design to execution—is essential to recruiting and retaining minority populations in clinical trials while mitigating researcher bias.
Dr. Stone’s impact extends beyond research. He spearheaded the creation of the Black Health Network in 1996, at a time when culturally sensitive health resources were scarce. The success of this initiative led to partnerships with companies like Amgen, for whom he recruited Black urologists and radiation oncologists to participate as principal investigators in a Phase 3 study involving Abarelix for prostate cancer. This collaboration not only surpassed recruitment goals among African Americans but also fueled Dr. Stone’s deep interest in clinical trial diversity and accessibility.
Additionally, Dr. Stone had the privilege of collaborating with Dr. Harold Freeman at Harlem Hospital, where he contributed to the groundbreaking "Clinical Navigator" model in breast cancer care. This work exemplified his commitment to bridging barriers that prevent underserved communities from accessing equitable healthcare.
These extensive experiences culminated in the establishment of TruVision Clinical Research Partners (TVCRP), a business model that prioritizes operational excellence, aggressive and inclusive recruitment methodologies, and cutting-edge technology to accelerate clinical trials. Dr. Stone’s leadership at TVCRP reflects a lifetime of dedication to ensuring that life-changing therapies reach broader populations more efficiently.
Our Leadership Team
TVCRP's leadership team reflects the community it serves by having multidisciplinary professionals including medical professionals, technology professionals and entrepreneurs with lived experience that informs a culturally competent approach to clinical trial design, execution and patient recruitment. Our team members are actively engaged with all relevant communities to ensure cultural, racial and ethical considerations are considered.
TVCRP's deep cultural competency and sensitivity in recruitment, patient engagement and retention strategies lead to greater engagement and participation from underrepresented groups. Many leading competitors (e.g. Medable or Parexel have diversity goals but do not incorporate the level of cultural competency that TVCRP's leadership brings.
Dr. Brian Stone, MD, FACS
Chief Executive Officer
Dr. Brian Stone, MD, FACS
Dr Brian Stone, MD, FACS serves as Chief Executive Officer at TruVision. He is a Board-Certified urologist with over 30 years of experience in the clinical trial space. Founder of BHN Inc. in 1997 which the first digital CRO focused on recruitment of underrepresented groups in clinical trials.
Vincent Akinola, MD
Chief Principal Investiagor
Vincent Akinola, MD
Dr. Vincent Akinola, MD serves as the Chief Prinicipal Investigator at TVCRP, and is a seasoned clinical trialist with over 11 years of experience as a clinical trial manager and principal investigator. Dr. Akinola Has managed an extensive sub investigator network
Chris Melson
Chief Finance Officer
Chris Melson, B.Sc CS, MBA
Chris Melson serves as the Chief Finance Officer of TVCRP. Chris is a CEO with over 25 years as a highly successful serial entrepreneur with multiple successful exits who is a seasoned technology executive with extensive experience in technology, business development and finance.
Dr. Lydell Lettsome, MD, FACS
Chief Medical Officer
Dr. Lydell Lettsome, MD, FACS
Dr. Lydell Lettsome, MD, FACS serves as the Chief Medical Officer at TruVision. Dr. Lettsome is a Board-Certified general surgeon with over 10 years of experience in the clinical trial space. Founder of the Vanberg Health Equity Group focused on addressing disparities and equal access to medical research.
Kimberly Kelly, PhD, CRNP
Chief of Clinical Navigation
Kimberly Kelly, PhD, CRNP
Dr.Kimberly Kelly serves as Chief of Navigation and Clinical Trial Coordination at TVCRP. She is a dedicated Doctor of Nursing and certified nurse practitioner working in direct patient care. She has extensive experience in managing clinical trials in the VA Health System. She is a certified Clinical Navigator.
Nadav Lankin, B.Sc CS, M.C.A.
Chief Data Scientist
Nadav Lankin, B.Sc CS, M.C.A.
Nadav Lankin serves as the Chief Data Scientist for TVCRP. He is a renowned data scientist specializing in High Performance Computing, Deep Learning, Cognitive Computing, Artificial Intelligance and high-end Computational Science. Nadav his developed Software as Medical Device (SaMD) systems and has extensive experience with FDA, HIPAA and SPIR grants.
David Warsing, MPA, MJ
Chief Administrator
David Warsing,MPA, MJ
David Warsing serves as Chief Operations Officer at TVCRP. David has 15 years in complex healthcare organizations, building relationships between hospitals, providers, and payors. He is skilled in organizational evaluations, contracts and negotiations, and program development
Montenia Edwards, MPH
Chief Of Clinical Operations
Montenia Edwards, MPH
Montenia Edwards serves as the Chief Clinical Officer at TruVision. Montenia is a seasoned clinical trials Project Manager with over 20 year of experience managing Phase I-IV clinical trials, post marketing trials and registry studies.
Lenore Coleman, PharmD
Chief Recruiting Officer
Lenore Coleman, PharmD
Dr. Lenore Coleman, PharmD serves as the Chief Recruiting Officer at TruVision. Dr. Coleman has been been a practicing pharmacist for over 45 years with a focus on the care and management of diabetes and CV diseases. She has over 30 years of experience in health disparities, community engagement and clinical trial management.
Richard Walker, MD, MBA
Chief Process Officer
Richard Walker, MD, MBA
Dr. Richard Walker MD, MBA serves as the Chief Process Officer at TVCRP. He is a retired Board-Certified obstetrician and gynecologist with over 40 years of experience in clinical medicine. Dr. Walker is the founder of TVP-care focused on developing patient centered technology for decentralize medical care and clinical trials.
Dr. Brian Stone, MD, FACS
Chief Executive Officer
Dr. Brian Stone, MD, FACS
Dr Brian Stone, MD, FACS serves as Chief Executive Officer at TruVision. He is a Board-Certified urologist with over 30 years of experience in the clinical trial space. Founder of BHN Inc. in 1997 which the first digital CRO focused on recruitment of underrepresented groups in clinical trials.
Vincent Akinola, MD
Chief Principal Investiagor
Vincent Akinola, MD
Dr. Vincent Akinola, MD serves as the Chief Prinicipal Investigator at TVCRP, and is a seasoned clinical trialist with over 11 years of experience as a clinical trial manager and principal investigator. Dr. Akinola Has managed an extensive sub investigator network
Lydell Lettsome, MD, FACS
Chief Medical Officer
Lydell Lettsome, MD, FACS
Dr. Lydell Lettsome, MD, FACS serves as the Chief Medical Officer at TruVision. Dr. Lettsome is a Board-Certified general surgeon with over 10 years of experience in the clinical trial space. Founder of the Vanberg Health Equity Group focused on addressing disparities and equal access to medical research.
Kimberly Kelly, PhD, CRNP
Chief of Clinical Navigation
Dr. Kimberly Kelly, PhD, CRNP
Dr.Kimberly Kelly serves as Chief of Navigation and Clinical Trial Coordination at TVCRP. She is a dedicated Doctor of Nursing and certified nurse practitioner working in direct patient care. She has extensive experience in managing clinical trials in the VA Health System. She is a certified Clinical Navigator.
Nadav Lankin, B.Sc CS, M.C.A.
Chief Data Scientist
Nadav Lankin, B.Sc CS, M.C.A.
Nadav Lankin serves as the Chief Data Scientist for TVCRP. He is a renowned data scientist specializing in High Performance Computing, Deep Learning, Cognitive Computing, Artificial Intelligance and high-end Computational Science. Nadav his developed Software as Medical Device (SaMD) systems and has extensive experience with FDA, HIPAA and SPIR grants.
Montenia Edwards, MPH
Chief Of Clinical Operations
Montenia Edwards, MPH
Montenia Edwards serves as the Chief Clinical Officer at TruVision. Montenia is a seasoned clinical trials Project Manager with over 20 year of experience managing Phase I-IV clinical trials, post marketing trials and registry studies.
Richard Walker, MD, MBA
Chief Process Officer
Richard Walker, MD, MBA
Dr. Richard Walker MD, MBA serves as the Chief Process Officer at TVCRP. He is a retired Board-Certified obstetrician and gynecologist with over 40 years of experience in clinical medicine. Dr. Walker is the founder of TVP-care focused on developing patient centered technology for decentralize medical care and clinical trials.
David Warsing, MPA, MJ
Chief Administrator
David Warsing,MPA, MJ
David Warsing serves as Chief Operations Officer at TVCRP. David has 15 years in complex healthcare organizations, building relationships between hospitals, providers, and payors. He is skilled in organizational evaluations, contracts and negotiations, and program development
Lenore Coleman, PharmD
Chief Recruiting Officer
Lenore Coleman, PharmD
Dr. Lenore Coleman, PharmD serves as the Chief Recruiting Officer at TruVision. Dr. Coleman has been been a practicing pharmacist for over 45 years with a focus on the care and management of diabetes and CV diseases. She has over 30 years of experience in health disparities, community engagement and clinical trial management.
Chris Melson
Chief Finance Officer
Chris Melson, B.Sc CS, MBA
Chris Melson serves as the Chief Finance Officer of TVCRP. Chris is a CEO with over 25 years as a highly successful serial entrepreneur with multiple successful exits who is a seasoned technology executive with extensive experience in technology, business development and finance.
About Us
We are the leader in innovation & execution of comprehensive patient recruitment and
clinical trial management.